Virenix Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Virenix General Information

Description

Developer of antiviral drugs for diseases. The company provides services in synergy with the research for antiviral drugs as well as provides access to a catalog of viral proteins, selling graphics software crystallography, expression and protein crystallography and the screening of viral proteins or virus for the discovery of new drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Primary Office
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Virenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Virenix’s complete valuation and funding history, request access »

Virenix Executive Team (1)

Name Title Board Seat Contact Info
Vincent L'Hermite Project Leader
To view Virenix’s complete executive team members history, request access »

Virenix Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Incubateur Impulse Accelerator/Incubator 000 0000 000000 0
To view Virenix’s complete investors history, request access »